CRBP vs. JANX

Last updated Aug 1, 2026

CRBP (Corbus Pharmaceuticals Holdings, Inc.) and JANX (Janux Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, CRBP returned -26.25%/yr vs -14.10%/yr for JANX. Their 0.23 correlation means their historical movements had little consistent relationship.

Performance

CRBP vs. JANX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Janux Therapeutics, Inc. (JANX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with CRBP having a 10.20% return and JANX slightly lower at 9.93%.

CRBP

• 1D: -0.88%
• 1M: -3.03%
• 6M: 8.46%
• YTD: 10.20%
• 1Y: -3.65%
• 3Y*: 7.40%
• 5Y*: -26.25%
• 10Y*: -20.07%
• ALL TIME*: -17.86%

JANX

• 1D: -2.63%
• 1M: -2.38%
• 6M: 10.65%
• YTD: 9.93%
• 1Y: -35.61%
• 3Y*: 4.64%
• 5Y*: -14.10%
• 10Y*: —
• ALL TIME*: -14.54%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CRBP Corbus Pharmaceuticals Holdings, Inc.	$2.30M	$2.68M	$4.28M
JANX Janux Therapeutics, Inc.	$12.19M	$13.52M	$15.80M

CRBP vs. JANX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CRBP Corbus Pharmaceuticals Holdings, Inc.	10.20%	-31.02%	95.36%	82.20%	-82.05%	-71.76%
JANX Janux Therapeutics, Inc.	9.93%	-74.22%	398.97%	-18.53%	-33.25%	-41.97%

Correlation

The correlation between CRBP and JANX is 0.35, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.35
Correlation (3Y) Balances recent behavior with more history.	0.29
Correlation (5Y) Shows whether the relationship held over a longer period.	0.23
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021	0.23

The correlation between CRBP and JANX shifts across timeframes, from 0.23 (all time) to 0.35 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CRBP : $166.19M JANX : $925.13M
EPS CRBP : -$5.72 JANX : -$1.84
PB Ratio CRBP : 1.33 JANX : 1.01
Total Revenue (TTM) CRBP : $0.00 JANX : $21.61M
Gross Profit (TTM) CRBP : -$149.00K JANX : $8.44M
EBITDA (TTM) CRBP : -$61.36M JANX : -$134.03M

Return for Risk

CRBP vs. JANX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CRBP

CRBP Risk / Return Rank: 44
CRBP Sharpe Ratio Rank: 42
CRBP Sortino Ratio Rank: 46
CRBP Omega Ratio Rank: 48
CRBP Calmar Ratio Rank: 43
CRBP Martin Ratio Rank: 43

JANX

JANX Risk / Return Rank: 26
JANX Sharpe Ratio Rank: 22
JANX Sortino Ratio Rank: 29
JANX Omega Ratio Rank: 27
JANX Calmar Ratio Rank: 24
JANX Martin Ratio Rank: 29

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CRBP vs. JANX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Janux Therapeutics, Inc. (JANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRBP	JANX	Difference
Sharpe ratio: Return per unit of total volatility	-0.04	-0.50	+0.46
Sortino ratio: Return per unit of downside risk	0.52	-0.17	+0.68
Omega ratio: Gain probability vs. loss probability	1.07	0.97	+0.11
Calmar ratio: Return relative to maximum drawdown	-0.05	-0.57	+0.52
Martin ratio: Return relative to average drawdown	-0.07	-0.77	+0.70

CRBP vs. JANX - Sharpe Ratio Comparison

The current CRBP Sharpe Ratio is -0.04, which is higher than the JANX Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of CRBP and JANX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CRBP vs. JANX - Drawdown Comparison

The maximum CRBP drawdown since its inception was -99.31%, which is greater than JANX's maximum drawdown of -83.14%. Use the drawdown chart below to compare losses from any high point for CRBP and JANX.

Drawdown Indicators

	CRBP	JANX	Difference
Max Drawdown Largest peak-to-trough decline	-99.31%	-83.14%	-16.17%
Max Drawdown (1Y) Largest decline over 1 year	-61.88%	-64.94%	+3.06%
Max Drawdown (3Y) Largest decline over 3 years	-92.01%	-81.78%	-10.23%
Max Drawdown (5Y) Largest decline over 5 years	-94.87%	-83.14%	-11.73%
Max Drawdown (10Y) Largest decline over 10 years	-99.31%	—	—
Current Drawdown Current decline from peak	-97.11%	-77.30%	-19.81%
Average Drawdown Average peak-to-trough decline	-66.40%	-53.27%	-13.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	45.40%	47.65%	-2.25%

Volatility

CRBP vs. JANX - Volatility Comparison

The current volatility for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is 11.86%, while Janux Therapeutics, Inc. (JANX) has a volatility of 12.76%. This indicates that CRBP experiences smaller price fluctuations and is considered to be less risky than JANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRBP	JANX	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.86%	12.76%	-0.90%
Volatility (6M) Calculated over the trailing 6-month period	59.99%	27.83%	+32.16%
Volatility (1Y) Calculated over the trailing 1-year period	79.24%	74.08%	+5.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	159.05%	130.51%	+28.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	129.03%	129.97%	-0.94%

Dividends

CRBP vs. JANX - Dividend Comparison

Neither CRBP nor JANX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CRBP and JANX in my portfolio?

CRBP and JANX have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRBP or JANX?

JANX has higher volatility (12.76%) compared to CRBP (11.86%). In terms of maximum drawdown, CRBP dropped -99.31% vs JANX's -83.14%.

Which has better risk-adjusted returns?

CRBP currently has the higher Sharpe Ratio (-0.04 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.